MindWalk Holdings Inks Agreement With Teva Pharmaceuticals Australia To Deploy ReefIQ

MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced a multi-year agreement with Teva Pharmaceuticals Australia Pty Ltd ("Teva Australia") to deploy ReefIQ™, MindWalk’s HYFT®-powered biological context layer with specified LensAI™ analytical capabilities, in support of a defined scope of antibody-discovery work. Teva Australia will use the AI capabilities to support discovery decisions based on generated predictions and accelerate antibody design optimization. MindWalk has been collaborating with Teva Australia since 2018.